HS Icon Vaccines, blood, antisera, toxins and cultures in  Flag United States

2020
Exports | Imports
: $29.8B | $44.9B, World Rnk 4 / 193
Flag Rnk 7 / 1217 | World Rnk 1 / 221
Flag Rnk 8 / 1214

2019 - 2020
FASTEST GROWING MARKET | FASTEST GROWING ORIGIN
: $916M | $2.72B, Japan |  Germany

2020
ECONOMIC COMPLEXITY of United States
: 1.56, Rnk 9 / 127

2020
PRODUCT COMPLEXITY  IN Vaccines, blood, antisera, toxins and cultures
: 1.23, Rnk 112 / 1029

Exports In 2020, United States exported $29.8B in Vaccines, blood, antisera, toxins and cultures, making it the 4th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 7th most exported product in United States. The main destination of Vaccines, blood, antisera, toxins and cultures exports from United States are: Germany ($4.11B), Netherlands ($3.04B), Switzerland ($2.56B), Japan ($2.22B), and China ($1.93B).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of United States between 2019 and 2020 were Japan ($916M), Ireland ($549M), and Germany ($506M).

Imports In 2020, United States imported $44.9B in Vaccines, blood, antisera, toxins and cultures, becoming the 1st largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 8th most imported product in United States. United States imports Vaccines, blood, antisera, toxins and cultures primarily from: Ireland ($12.8B), Belgium ($7.3B), Germany ($7.07B), Switzerland ($3.54B), and Netherlands ($2.26B).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for United States between 2019 and 2020 were Germany ($2.72B), Belgium ($1.94B), and Ireland ($1.81B).

August 2022

Subnational Monthly Trade

#permalink to section
Time Scale
Flow
Value

EXPORT GROWTH (August 2021 - August 2022): $6.63M, (0.17%)

IMPORT GROWTH (August 2021 - August 2022): $-634M, (-11.2%)

MAIN EXPORTER (August 2022): North Carolina, $806M

MAIN DESTINATION (August 2022): China, $764M

This section shows Vaccines, blood, antisera, toxins and cultures's exports and imports data at subnational level for United States. Click any date in the line plot, any subnational region in the geomap, or any destination or origin country to explore the exports or imports behavior of Vaccines, blood, antisera, toxins and cultures over time.

For full datasets download visit Bulk Download page.

Go to Bulk Download

Historical Data

#permalink to section
Value
Compare to

EXPORTS (2020): $29.8B

IMPORTS (2020): $44.9B

NET TRADE (2020): -$15.2B

In 2020, United States exported $29.8B in Vaccines, blood, antisera, toxins and cultures. The main destinations of United States exports on Vaccines, blood, antisera, toxins and cultures were Germany ($4.11B), Netherlands ($3.04B), Switzerland ($2.56B), Japan ($2.22B), and China ($1.93B).

In 2020, United States imported $44.9B in Vaccines, blood, antisera, toxins and cultures, mainly from Ireland ($12.8B), Belgium ($7.3B), Germany ($7.07B), Switzerland ($3.54B), and Netherlands ($2.26B).

Explore Visualizations

Flow

THE FASTEST GROWING Vaccines, blood, antisera, toxins and cultures EXPORT MARKETS FOR United States WERE (2019 - 2020):

THE FASTEST DECLINING MARKETS FOR THE EXPORT OF Vaccines, blood, antisera, toxins and cultures BY United States WERE (2019 - 2020):

Explore Visualizations

Market Concentration

#permalink to section
View
Flow
Type

In 2020, United States's main exporting competitors in Vaccines, blood, antisera, toxins and cultures were:

In 2020, United States's main importing competitors in Vaccines, blood, antisera, toxins and cultures were:

Explore Visualizations